Structures by: Qin X. Y.
Total: 14
C20H24Br2Cu2N2O12S2,2(H2O)
C20H24Br2Cu2N2O12S2,2(H2O)
Metallomics : integrated biometal science (2020) 12, 1 92-103
a=12.248(3)Å b=7.6422(18)Å c=15.829(4)Å
α=90.00° β=104.923(4)° γ=90.00°
C22H18BrCuN3O5S,CH4O
C22H18BrCuN3O5S,CH4O
Metallomics : integrated biometal science (2020) 12, 1 92-103
a=15.516(8)Å b=13.3471(7)Å c=11.7999(9)Å
α=90.00° β=100.625(19)° γ=90.00°
C48H56Cu4N8O16S4
C48H56Cu4N8O16S4
Dalton transactions (Cambridge, England : 2003) (2020) 49, 18 6043-6055
a=14.2730(3)Å b=14.2730(3)Å c=13.9589(3)Å
α=90° β=90° γ=90°
2(C48H52Br4Cl4Cu4N4O8S4),4(H2O)
2(C48H52Br4Cl4Cu4N4O8S4),4(H2O)
Dalton transactions (Cambridge, England : 2003) (2020) 49, 18 6043-6055
a=10.1515(3)Å b=13.6106(4)Å c=22.1971(9)Å
α=85.732(3)° β=84.872(3)° γ=85.986(2)°
C23H15BrO2S
C23H15BrO2S
Chemical Communications (2019)
a=8.4326(7)Å b=11.5349(9)Å c=18.9409(15)Å
α=90.00° β=91.0070(10)° γ=90.00°
C26H38Cu2N8O10,8(H2O)
C26H38Cu2N8O10,8(H2O)
Dalton transactions (Cambridge, England : 2003) (2013) 42, 41 14681-14684
a=30.60(6)Å b=7.415(14)Å c=8.890(16)Å
α=90.00° β=90.00° γ=90.00°
C36H38Cu2N4O10,2(H2O)
C36H38Cu2N4O10,2(H2O)
Dalton transactions (Cambridge, England : 2003) (2013) 42, 41 14681-14684
a=7.3882(5)Å b=29.4687(19)Å c=8.6809(6)Å
α=90.00° β=99.775(7)° γ=90.00°
C22H20BrCoN3O6S,C2H6O
C22H20BrCoN3O6S,C2H6O
Metallomics : integrated biometal science (2020) 12, 1 92-103
a=15.5234(7)Å b=19.2687(5)Å c=19.1761(8)Å
α=90.00° β=112.933(5)° γ=90.00°
(R*,S*)-2,2'-(Ethane-1,2-diyldiimino)dibutan-1-ol
C10H24N2O2
Acta Crystallographica Section E (2006) 62, 10 o4222-o4223
a=4.6334(13)Å b=5.4777(14)Å c=23.161(2)Å
α=90.00° β=95.336(6)° γ=90.00°
(2S,3S,5R)-Diphenylmethyl 4,4-dioxo-3-(1,2,3-triazol-1-ylmethyl)-2-penicillanate
C23H22N4O5S
Acta Crystallographica Section E (2006) 62, 11 o4997-o4998
a=9.7075(14)Å b=10.5271(16)Å c=21.650(3)Å
α=90.00° β=90.00° γ=90.00°
Diphenylmethyl 1-oxo-1-penicillanate
C21H21NO4S
Acta Crystallographica Section E (2006) 62, 10 o4391-o4392
a=7.9978(14)Å b=9.5959(17)Å c=24.020(5)Å
α=90.00° β=90.00° γ=90.00°
(S,S)-N,N'-Bis(2-hydroxy-2-butyl)ethylenediammonium oxalate pentahydrate
C10H26N2O22,C2O42,5H2O
Acta Crystallographica Section E (2006) 62, 10 o4567-o4568
a=8.2104(15)Å b=10.3092(19)Å c=23.771(5)Å
α=90.00° β=90.00° γ=90.00°
4,4,5,5-Tetramethyl-2-[4-(2-pyridyl)phenyl]-3,4-dihydroimidazole-1-oxyl-3-oxide
C18H20N3O2
Acta Crystallographica Section E (2009) 65, 5 o1031
a=8.5150(17)Å b=22.286(5)Å c=9.1360(18)Å
α=90.00° β=109.45(3)° γ=90.00°
4-Amino-3,5-dichlorobenzenesulfonamide
C6H6Cl2N2O2S
Acta Crystallographica Section E (2010) 66, 11 o2838
a=8.9544(17)Å b=13.387(3)Å c=7.5673(15)Å
α=90.00° β=95.809(2)° γ=90.00°